-
-
-
-
-
-
-
Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
-
-
-
-
-
-
-
Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine
-
-
-
-
-
-
-
Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville
-
-
-
-
-
-
-
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology
-
-
-
-
-
-
-
Recro Pharma (REPH) Tops Q3 EPS by 6c, Revenues Beat; Raises 2018 CDMO Guidance
-
-
-
-
-
-
-
Recro Pharma Announces PDUFA Date for IV Meloxicam
-
-
-
-
-
-
-
Recro Pharma Announces Commercial Team Additions
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

